FAM
ONCT

Formidable Asset Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Formidable Asset Management’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1
Closed -$3K – 511
2013
Q3 		$3K Buy
+1
New +$4.98K ﹤0.01% 403

Other funds holding ONCT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Formidable Asset Management's ONCT Position: Q4 2013 in Review

Formidable Asset Management sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2013, closing a stake of 1 share — an estimated $3K sold.

Formidable Asset Management first reported a position in ONCT in Q3 2013 and held it in 1 quarter. The position peaked at $3K in Q3 2013. 58 funds tracked by Wall St. Rank hold ONCT as of Q4 2013.

  • Formidable Asset Management reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Formidable Asset Management sold 1 Oncternal Therapeutics, Inc. Common Stock share in Q4 2013, an estimated $3K.
  • Formidable Asset Management first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q3 2013 and held it in 1 quarter.
  • Formidable Asset Management's Oncternal Therapeutics, Inc. Common Stock position peaked at $3K in Q3 2013.
  • 58 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2013.

Based on Formidable Asset Management's 13F filing for Q4 2013, filed 18 Feb 2014.